GSK plc quarter change: Foreign Other Stocks, Sold out
In shares no fund filing gives a ticker for, so this site has no page for them (depositary receipts and foreign shares traded over the counter), from the quarter ended 2026-03-31 to 2026-06-30, GSK plc opened 0 positions, added to 0, reduced 0, sold out of 0 and left 0 unchanged.
Two Form 13F-HR filings compared (SEC CIK 1131399): 2026-03-31 (filed 2026-05-14) and 2026-06-30 (filed 2026-08-13). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
No position of this class changed this way between the two filings.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Warberg Asset Management LLC | United States | $0.600B | 192 |
| Matthew Goff Investment Advisor, LLC | United States | $0.600B | 107 |
| Stanley Capital Management, LLC | United States | $0.598B | 40 |
| Beverly Hills Private Wealth, LLC | United States | $0.600B | 499 |
| LONE PEAK GLOBAL INVESTORS LLC | United States | $0.600B | 42 |
| Financial Strategies Group, Inc. | United States | $0.598B | 101 |
| Citizens National Bank Trust Department | United States | $0.601B | 382 |
| Clear Trail Advisors, LLC | United States | $0.601B | 149 |
| Estuary Capital Management LP | United States | $0.598B | 22 |
| ORRSTOWN FINANCIAL SERVICES INC | United States | $0.597B | 123 |